CBD-Based Drug Combination Therapy May Potentially Treat Rheumatoid Arthritis



Incannex, an Australian pharmaceutical company, announced the first dosing in a Phase 2 study of IHL-675A, the company’s …

Be the first to comment

Leave a Reply

Your email address will not be published.


*